PainTEQ Exceeds 75% Enrollment in Landmark SI Joint Fusion Study
Patient enrollment nears completion in investigational study expanding research of sacroiliac joint dysfunction treatment using a novel therapeutic device.
News provided by
Share this article
Share this article
TAMPA, Fla., March 15, 2021 /PRNewswire/ In the wave of innovative medical technology, PainTEQ, in partnership with Evolve Restorative Center in Santa Rosa, California and Celeri Health in Wilmington, Delaware, quickly nears enrollment completion of their single-arm multicenter prospective study exploring SI joint fusion using PainTEQ s posterior approach.
Enrollment continues for patients who have been treated for SI joint dysfunction using the LinQ™ Sacroiliac Joint Fusion System, a potential new standard of care for patients who have not responded to conservative SI joint treatments. PainTEQ s LinQ is a minimally-invasive treatment for patients with chronic SI joint pain, making it a more attractiv
PainTEQ Exceeds 75% Enrollment in Landmark SI Joint Fusion Study prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.